20688-91-9

Basic information

• Product Name: methyl 3,4-O-isopropylidene-6-O-(p-toluenesulfonyl)-β-D-galactopyranoside
• Synonyms: methyl 3,4-O-isopropylidene-6-O-(p-toluenesulfonyl)-β-D-galactopyranoside
• CAS NO: 20688-91-9
• Molecular Weight: 388.439
• Mol File: 20688-91-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 3,4-O-isopropylidene-6-O-(p-toluenesulfonyl)-β-D-galactopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3,4-O-isopropylidene-6-O-(p-toluenesulfonyl)-β-D-galactopyranoside(20688-91-9)
• EPA Substance Registry System: methyl 3,4-O-isopropylidene-6-O-(p-toluenesulfonyl)-β-D-galactopyranoside(20688-91-9)

Safety Data

• Hazardous Substances Data: 20688-91-9(Hazardous Substances Data)

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 14897-47-3 methyl 3,4-di-O-isopropylidene-β-D-galactopyranoside 

Downstream Products

• 182167-61-9 Toluene-4-sulfonic acid (3aS,4R,6R,7R,7aS)-6-methoxy-7-(4-methoxy-benzyloxy)-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-4-ylmethyl ester 
• 79526-26-4 methyl 2-O-benzoyl-6-O-tosyl-β-D-galactopyranoside 
• 182167-68-6 Benzoic acid (2R,3R,5R,6R)-6-ethylsulfanyl-5-(4-methoxy-benzyloxy)-2-methyl-tetrahydro-pyran-3-yl ester 
• 182167-69-7 Benzoic acid (2R,3R,5R,6S)-6-ethylsulfanyl-5-(4-methoxy-benzyloxy)-2-methyl-tetrahydro-pyran-3-yl ester 
• 182167-88-0 Allyl 2-O-benzoyl-3-O-[4-O-benzoyl-3,6-dideoxy-2-O-(p-methoxybenzyl)-α-D-xylo-hexopyranosyl]-4,6-di-O-(p-methoxybenzyl)-α-D-mannopyranoside 
• 182167-90-4 Allyl 2-O-benzoyl-3-O-(4-O-benzoyl-3,6-dideoxy-α-D-xylo-hexopyranosyl)-α-D-mannopyranoside 
• 182167-67-5 Benzoic acid (2R,3R,5R,6R)-6-methoxy-5-(4-methoxy-benzyloxy)-2-methyl-tetrahydro-pyran-3-yl ester 
• 182167-65-3 Methyl 2-O-(p-methoxybenzyl)-3,4-O-sulfonyl-β-D-fucopyranoside 
• 182167-63-1 Methyl 3,4-O-isopropylidene-2-O-(p-methoxybenzyl)-β-D-fucopyranoside 

Relevant articles and documents

Synthesis of glycose carbamides and evaluation of the induction of erythroid differentiation of human erythroleukemic K562 cells

A series of carbamides derived from 1,2:5,6-di-O-isopropylidene-d-gluco- (1) and d-allofuranose (3) as well as their 5,6-O-deprotected analogues (2 and 4) and methyl 3,4-O-isopropylidene-α- and β-d-galactopyranosides (5 and 6) have been prepared in order to evaluate their ability to induce erythroid differentiation of human erythroleukemic K562 cells. Twenty out of 51 carbamides tested exhibit an appreciable activity as inducers of erythroid differentiation and have been fully characterized and described.

Synthesis of labilose, a component of the antibiotic labilomycin and structural revision of flambamycin by high resolution high field 13C N.M.R. spectroscopy

-